P55 | MANAGEMENT OF NEUROLOGICAL TOXICITIES OF PATIENTS TREATED WITH IMMUNOTHERAPIES FOR MULTIPLE MYELOMA: A SINGLE-CENTER REAL WORLD EXPERIENCE
T cell redirecting therapies (TCRt) have dramatically improved the prognosis of relapsed/refractory multiple myeloma (RRMM) patients (pts), but they are also burdened by novel toxicities, among which neurological ones such as immune cell associated neurotoxicity syndrome (ICANS), headache, and neur...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Ferrata Storti Foundation
2026-04-01
|
| Schriftenreihe: | Haematologica |
| Online-Zugang: | https://haematologica.org/article/view/14068 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
